Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Common baldness treatments include cosmetic methods, medication like minoxidil, and surgery, but no cure exists.

Finasteride may help treat hidradenitis suppurativa in children, but concerns exist about ethics, safety, and proper use.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Permanent hair removal with lasers is the most promising treatment for excessive hair growth.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Both hormonal and non-hormonal therapies improve hair growth in women, but non-hormonal methods may be more effective with fewer side effects.

Integrative hair therapy improved hair loss and regrowth.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Low-dose effects in rodent studies are hard to confirm due to confounding factors and control group variability.

Hypertrichosis and hirsutism can cause psychological issues, with laser treatments being the most promising for permanent hair removal.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Minoxidil and finasteride combined can effectively treat hair loss.

Topical minoxidil is the primary treatment for female pattern hair loss in India.

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

Female pattern hair loss causes thinning hair on top of the scalp, treatable with limited success.

Topical minoxidil helps hair regrowth in over 50% of men and women.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Menopausal acne is mainly caused by hormonal changes and can be managed with topical treatments, lifestyle changes, and sometimes medication.

AT-Grow, a natural product, might help with a common type of hair loss by reducing DHT levels.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.